Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Duke who wrote (2830)	7/24/1999 9:08:00 AM
From: Sylvester	Read Replies (1) \| Respond to of 4140

24 hours out, the anger subsided, and my problem is that I broke all my own rules in being so invested in one stock. Killer!!! Not that the it will help much, but the FDA meeting made no sense. Onr of two things happened. The ODP members were jealous of the presenters who on that day had over $140,000,000 of equity. They converted this jealousy into suspicion about the data. "Couldn't they be lying for $140,000,000?" Doesn't need to be a conspiracy for the though in anyones mind that folks will lie for that much money. This doesn't change the facts. The FDA must quickly decide if the protocal at this meeting was consistant, and if not, act to rectify without punishing Sunrise further. The analyst from Kinnard, was informed, well spoken, but completely wrong about their being too many players. For me, and thousands like me, the demand is for the safety of Sunrise, and their rejection is double frustrating. There is a possibility that members of the panel took bribes, but this doesn't necessarily have to be true to explain their vote. We have no choice but to wait and see, but I'd be surprised if the FDA simply accepted the recommendation without question and ended this for once and for all.